They found that antibodies in the serum of hepatitis phase patients with alanine aminotransferase (ALT) flares recognized more epitopes than those in chronic infection phase, and that the number of epitopes recognized by antibodies in the serum rose as patients moved from chronic infection phase to hepatitis phase patients with ALT flares. The gene discussed is GPT; the disease is hepatitis A virus infection.